Zydus Wellness Limited Submits Q4FY26 SEBI Compliance Certificate for Dematerialization Process

1 min read     Updated on 11 Apr 2026, 02:13 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Zydus Wellness Limited filed its Q4FY26 compliance certificate under SEBI Regulation 74(5) on April 11, 2026, confirming proper dematerialization procedures for equity shares during the quarter ended March 31, 2026. The company's registrar MUFG Intime India Private Limited validated that all dematerialization activities were conducted within regulatory timelines with appropriate verification processes.

powered bylight_fuzz_icon
37442633

*this image is generated using AI for illustrative purposes only.

Zydus Wellness Limited has submitted its quarterly compliance certificate to stock exchanges for the quarter ended March 31, 2026, in accordance with SEBI regulatory requirements. The filing demonstrates the company's adherence to dematerialization procedures and investor service standards.

Regulatory Compliance Certificate

The company filed its certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 with both BSE Limited and National Stock Exchange of India Limited on April 11, 2026. Company Secretary and Compliance Officer Nandish P. Joshi signed the compliance document confirming proper dematerialization procedures.

Parameter: Details
Reporting Period: Quarter ended March 31, 2026
Filing Date: April 11, 2026
BSE Code: 531335
NSE Symbol: ZYDUSWELL
Signatory: Nandish P. Joshi, Company Secretary

Dematerialization Process Confirmation

Zydus Wellness confirmed that all equity share certificates received for dematerialization during Q4FY26 were properly processed. The company verified that certificates were mutilated and cancelled only after due verification, with the respective depository names substituted as registered owners for dematerialized equity shares.

The securities comprised in the certificates have been listed on BSE Limited and National Stock Exchange of India Limited, maintaining consistency with the company's existing listed securities.

Registrar Confirmation

MUFG Intime India Private Limited, formerly Link Intime India Private Limited, served as the company's registrar and transfer agent for the reporting period. The registrar provided confirmation on April 1, 2026, validating the dematerialization process compliance.

Service Provider: Details
Registrar: MUFG Intime India Private Limited
Former Name: Link Intime India Private Limited
Confirmation Date: April 1, 2026
Authorized Signatory: Amit Kumar Banerjee
Location: Ahmedabad

The registrar confirmed that securities received from depository participants during Q4FY26 were processed within prescribed timelines, with proper verification and cancellation procedures followed for physical certificates.

Corporate Information

Zydus Wellness Limited operates from its registered office at Zydus Corporate Park, Scheme No. 63, Survey No. 536, Khoraj, Gandhinagar, near Vaishnodevi Circle, S.G. Highway, Ahmedabad. The company maintains its corporate identity number L15201GJ1994PLC023490 and continues its focus on wellness and nutrition products under the tagline "nourish • nurture • energize."

How might the registrar's name change from Link Intime to MUFG Intime India impact Zydus Wellness's investor servicing capabilities and costs?

What strategic initiatives is Zydus Wellness likely to announce in their upcoming Q4FY26 earnings results following this compliance filing?

Could increased dematerialization activity during Q4FY26 indicate potential corporate actions or institutional investor interest in Zydus Wellness shares?

like19
dislike

Zydus Wellness Clarifies Significant Volume Movement in Equity Shares to BSE

1 min read     Updated on 07 Apr 2026, 04:19 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Zydus Wellness Limited responded to BSE surveillance inquiry about significant equity volume increases, confirming compliance with SEBI disclosure regulations. The company stated no undisclosed events exist that could impact share movement and attributed volume surge to market-driven factors. The wellness company reaffirmed its commitment to ongoing regulatory compliance under SEBI Listing Obligations.

powered bylight_fuzz_icon
37104545

*this image is generated using AI for illustrative purposes only.

Zydus Wellness Limited has issued a clarification to BSE Limited regarding significant volume movement in its equity shares, responding to a surveillance inquiry dated April 7, 2026. The company addressed concerns about increased trading activity across exchanges in recent periods.

Regulatory Compliance and Disclosure Status

In its response to BSE surveillance reference number L/SURV/ONL/PV/SG/2026-2027/11, Zydus Wellness confirmed that it has made all necessary disclosures under regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. The company emphasized that there are no undisclosed events or information, including any impending announcements, that could influence the price or volume behavior of its equity shares.

Company's Position on Volume Movement

Zydus Wellness attributed the significant increase in trading volumes to market-driven factors, stating that the company has neither control over nor knowledge of the specific reasons behind this movement. The wellness company maintained that such volume fluctuations are purely market-driven phenomena.

Parameter: Details
BSE Code: 531 335
Inquiry Date: April 7, 2026
Regulation: SEBI Listing Obligations Regulation 30
Response Officer: Nandish P. Joshi, Company Secretary

Ongoing Compliance Commitment

The company reaffirmed its commitment to regulatory compliance, stating that it will continue to make necessary disclosures of events and information in accordance with regulation 30 of the Listing Regulations. This response demonstrates Zydus Wellness's adherence to transparency requirements and proactive communication with regulatory authorities.

The clarification was signed by Nandish P. Joshi, Company Secretary and Compliance Officer, and submitted to BSE surveillance for record purposes.

Will Zydus Wellness face additional regulatory scrutiny or monitoring measures following this volume spike investigation?

Could this unusual trading activity signal potential merger or acquisition interest from other pharmaceutical companies?

How might sustained high trading volumes impact Zydus Wellness's stock liquidity and institutional investor interest going forward?

like20
dislike

More News on Zydus Wellness